| Covenant Waiver Extension | 15-Apr-2026 | 07:30 | RNS |
| Interim results for the HY ended 31 December 2025 | 31-Mar-2026 | 07:00 | RNS |
| Notice of H1 Results, Trading update and IMC | 25-Mar-2026 | 07:00 | RNS |
| Judgment Delivered in Commercial Litigation Claim | 17-Mar-2026 | 07:00 | RNS |
| Judgment Delivered in Commercial Litigation Claim | 17-Mar-2026 | 07:00 | RNS |
| Update on Case Investment and Strategic Review | 11-Mar-2026 | 09:34 | RNS |
| Update on Case Investment and Strategic Review | 11-Mar-2026 | 09:34 | RNS |
| Covenant Waiver Extension | 02-Mar-2026 | 07:00 | RNS |
| Increase in Credit Facility and Waiver Extension | 02-Feb-2026 | 07:00 | RNS |
| Positive development on case | 12-Jan-2026 | 14:07 | RNS |
| Covenant Waiver Extension | 30-Dec-2025 | 07:00 | RNS |
| Covenant Waiver Extension | 30-Dec-2025 | 07:00 | RNS |
| Adverse Costs Order in Class Action Investment | 24-Dec-2025 | 07:00 | RNS |
| Results of AGM | 27-Nov-2025 | 13:08 | RNS |
| Strategic Review Update | 26-Nov-2025 | 17:00 | RNS |
| Currency | UK Pounds |
| Share Price | 4.59p |
| Change Today | 0.29p |
| % Change | 6.74 % |
| 52 Week High | 58.00 |
| 52 Week Low | 3.86 |
| Volume | 21,812 |
| Shares Issued | 114.28m |
| Market Cap | £5.25m |
| RiskGrade | 218 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Latest | Previous | |
|---|---|---|
| Final | Final | |
| Ex-Div | 03-Oct-24 | 28-Sep-23 |
| Paid | 25-Oct-24 | 27-Oct-23 |
| Amount | 1.25p | 2.25p |
| Time | Volume / Share Price |
| 15:52 | 830 @ 4.58p |
| 15:52 | 830 @ 4.59p |
| 15:52 | 80 @ 4.59p |
| 13:47 | 644 @ 4.59p |
| 13:20 | 2,000 @ 4.50p |
| CEO | Patrick Moloney |
| CFO | David Collins |
You are here: research